MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation Total Non Current Liabilities 2011-2026 | NEOG
Annual Total Non Current Liabilities Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 19.6 M | 19.1 M | 20.6 M | 19 M | 15.8 M | 14 M | 14.6 M | 12.6 M | 12.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 M | 12.6 M | 16.5 M |
Quarterly Total Non Current Liabilities Neogen Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.6 M | 16.7 M | 16.6 M | 15.8 M | 15.8 M | 15 M | 14.3 M | 14 M | 14 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 13.6 M | 12.6 M | 12.6 M | 12.6 M | 12.8 M | 12.8 M | 12.9 M | 12.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.7 M | 12.6 M | 14.3 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
BioNano Genomics
BNGO
|
16.4 M | $ 1.12 | -0.88 % | $ 1.42 M |  USA |
 |
Brainsway Ltd.
BWAY
|
7.58 M | $ 24.41 | 1.2 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 27.63 | -4.06 % | $ 297 M |  China |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Celcuity
CELC
|
69.2 K | $ 105.79 | 0.61 % | $ 4.17 B | USA |
 |
Danaher Corporation
DHR
|
26.9 B | $ 209.19 | -0.82 % | $ 149 B | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
25.8 M | $ 11.26 | - | $ 319 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | Israel |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 23.09 | 0.35 % | $ 698 M | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
3.56 M | - | - | $ 79.8 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 209.54 | 1.02 % | $ 23.3 B | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 29.94 | 3.46 % | $ 832 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 19.25 | 2.45 % | $ 1.03 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 287.13 | 0.64 % | $ 23.9 B | USA |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
1.15 B | $ 73.09 | -0.23 % | $ 28.5 B | USA |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Myriad Genetics
MYGN
|
107 M | $ 4.43 | 1.14 % | $ 410 M | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | $ 103.45 | 0.06 % | $ 19.5 B | USA |
 |
Natera
NTRA
|
124 M | $ 209.53 | 0.09 % | $ 20.6 B | USA |
 |
Pacific Biosciences of California
PACB
|
43.9 M | $ 1.66 | 5.06 % | $ 421 M | USA |
 |
Guardant Health
GH
|
91.4 M | $ 95.4 | 1.04 % | $ 12 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 31.5 | 0.9 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
1.58 B | - | - | $ 10.6 B | Niderland |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 166.06 | 1.55 % | $ 8.23 B | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 104.09 | -0.54 % | $ 8.59 B |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
1.29 M | $ 3.86 | 2.93 % | $ 2.07 M | USA |
 |
IDEXX Laboratories
IDXX
|
597 M | $ 649.23 | 4.19 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
2.04 B | $ 122.9 | 1.96 % | $ 19.5 B | USA |
 |
IQVIA Holdings
IQV
|
13 B | $ 164.88 | 1.58 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
1.61 B | $ 1 379.66 | -0.97 % | $ 28.4 B |  Schweiz |
 |
Trinity Biotech plc
TRIB
|
106 M | $ 0.75 | 6.99 % | $ 61.9 M | Irlanda |
|
Biodesix
BDSX
|
62.1 M | $ 13.02 | 1.96 % | $ 1.69 B | USA |
 |
Quidel Corporation
QDEL
|
202 M | $ 21.93 | 3.49 % | $ 924 M | USA |
 |
Twist Bioscience Corporation
TWST
|
4.56 M | $ 48.54 | 0.94 % | $ 2.9 B | USA |